Clinical Trials Directory

Trials / Conditions / Neoplasms Pancreatic

Neoplasms Pancreatic

19 registered clinical trials studyying Neoplasms Pancreatic — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmunoPET Imaging of Pancreatic Cancer
NCT06602037
RenJi HospitalN/A
WithdrawnA Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreat
NCT06498518
Karen CartyPhase 2
Active Not RecruitingStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Ca
NCT05669482
Verastem, Inc.Phase 1 / Phase 2
CompletedPreventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsie
NCT04566614
Royal Marsden NHS Foundation Trust—
WithdrawnA Pilot Study of BXCL701 in Patients With Pancreatic Cancer
NCT04123574
BioXcel Therapeutics IncEARLY_Phase 1
CompletedA New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma
NCT05547074
Zhejiang University—
CompletedDelay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confineme
NCT06118125
University of Bordeaux—
TerminatedPRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Ca
NCT04176952
Judith Dixon-HughesPhase 2
Active Not Recruiting9-ING-41 in Patients With Advanced Cancers
NCT03678883
Actuate Therapeutics Inc.Phase 2
CompletedA Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
NCT02905578
Joseph J. CullenPhase 2
TerminatedFirst-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults
NCT03681951
GlaxoSmithKlinePhase 2
CompletedA Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cance
NCT03535727
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 / Phase 2
UnknownPrecision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer
NCT04161417
Judith Dixon-HughesN/A
UnknownPRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Canc
NCT04151277
Judith Dixon-HughesPhase 2
WithdrawnThe Effect of Cannabis in Pancreatic Cancer
NCT03245658
Jens Rikardt AndersenPhase 2
TerminatedPercutaneous Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
NCT03187587
Clinical Laserthermia Systems ABN/A
CompletedImmunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
NCT02973217
Clinical Laserthermia Systems ABN/A
TerminatedGemcitabine and CT-011 for Resected Pancreatic Cancer
NCT01313416
Augusta UniversityPhase 2
CompletedPhase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic C
NCT01446458
Emory UniversityPhase 1